47 Rue Adrienne Bolland
Discovering effective drug candidates for preclinical development requires innovative and reliable science; from disease models to tailored assays and robust high-throughput screening systems.
Ncardia combines cardiovascular and neural cell expertise with commercial iPSC manufacturing experience to provide you with predictive and translational assays at any throughput. Our integrated Drug Discovery platform gives you a flexible solution to integrate hiPSC disease models into your cardiac and neuronal drug discovery campaigns, tailored to your project needs.
Through the different phases of our campaign, we help you assess the efficacy of your compounds, step by step, to get you the results you need: